Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury. - Wikidata - wikimedia - TriplyDB

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury.

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury.

http://www.wikidata.org/entity/Q44060069

about

Low dose intravenous minocycline is neuroprotective after middle cerebral artery occlusion-reperfusion in rats Prothrombin Kringle-2: A Potential Inflammatory Pathogen in the Parkinsonian Dopaminergic System The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders What are the Best Animal Models for Testing Early Intervention in Cerebral Palsy?Antimicrobial peptides and complement in neonatal hypoxia-ischemia induced brain damage Profile of minocycline and its potential in the treatment of schizophrenia The yin and yang of microglia Cocktail treatment, a promising strategy to treat acute cerebral ischemic stroke?Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria Clinically approved heterocyclics act on a mitochondrial target and reduce stroke-induced pathology.Normobaric hyperoxia combined with minocycline provides greater neuroprotection than either alone in transient focal cerebral ischemia.Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke.Transmission and detection of prions in feces Role of microglia in a mouse model of paediatric traumatic brain injury The Effects of Chunghyul-Dan, an Agent of Korean Medicine, on a Mouse Model of Traumatic Brain Injury Targeting microglial activation in stroke therapy: pharmacological tools and gender effects.HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.Ontogeny and functions of central nervous system macrophages.Involvement of microglia activation in the lead induced long-term potentiation impairment.Minocycline protects against neurologic complications of rapid correction of hyponatremia.Improving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in mice Minocycline causes widespread cell death and increases microglial labeling in the neonatal mouse brain.Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis.Neuroinflammation and neuroimmune dysregulation after acute hypoxic-ischemic injury of developing brain Neuroinflammation modulates distinct regional and temporal clinical responses in ALS mice.The developing oligodendrocyte: key cellular target in brain injury in the premature infant Deleterious effects of minocycline after in vivo target deprivation of thalamocortical neurons in the immature, metallothionein-deficient mouse brain.MCP-induced protein 1 mediates the minocycline-induced neuroprotection against cerebral ischemia/reperfusion injury in vitro and in vivo.Minocycline development for acute ischemic stroke Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial Lithium-mediated long-term neuroprotection in neonatal rat hypoxia-ischemia is associated with antiinflammatory effects and enhanced proliferation and survival of neural stem/progenitor cells.Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms.Role of oral Minocycline in acute encephalitis syndrome in India - a randomized controlled trial.Hypoxic Preconditioning Suppresses Glial Activation and Neuroinflammation in Neonatal Brain Insults.Oligodendroglial maldevelopment in the cerebellum after postnatal hyperoxia and its prevention by minocycline.Short and long-term analysis and comparison of neurodegeneration and inflammatory cell response in the ipsilateral and contralateral hemisphere of the neonatal mouse brain after hypoxia/ischemia.Mechanisms of reovirus-induced cell death and tissue injury: role of apoptosis and virus-induced perturbation of host-cell signaling and transcription factor activation.Minocycline as a neuroprotective agent.The role of inflammation in perinatal brain injury.Combination Therapies for Traumatic Brain Injury: Retrospective Considerations

P2860

Q24800152-3FD8B02F-7747-498A-BCBC-B19C7381A334 Q26738336-6FF74323-FBDA-4E29-97BD-E775298B7A49 Q26777952-A1D5D0AE-7F67-42C0-9D00-A4BEDCF5F9A3 Q26829589-D47AD003-2719-4E5D-908B-DBB990D0A5F9 Q26850135-E41B17AF-B4CF-478B-8A24-7F13C67E77F6 Q26864400-0F090842-484A-46A4-8A33-7BA99A4826D1 Q27693871-A7FF5D66-0791-4E84-98C3-758100539F1F Q28077232-DD7FA8CB-E2DD-49C3-A222-6D8B5C82321F Q28574259-3C19DA9B-4B68-474B-896F-FAD70C45B1E8 Q33204952-A1A4F202-BF3C-4C06-9337-8C2238B41320 Q33456516-9EB42B56-59F8-405B-981D-F1D7A900BDD0 Q33508929-3E1637EB-23C5-45F1-A31E-54E10052AC2B Q33579436-3095ED58-C32E-4A71-BD30-BAC325AE58B2 Q33718924-3D16346A-2B30-414F-8D3C-85653C2D22C2 Q33823964-F1AEE7CF-E3FA-4B29-954B-7991FAB0B9FF Q33824991-70CD43BF-4686-4C67-B38E-EB2EB9A6DCB0 Q34037622-67774AB4-CB6A-44F1-BF36-2B36CE79822F Q34147513-6520FB21-F782-497F-8A61-595E13D043A0 Q34405848-B675FB5F-0470-4BD0-BB19-59F0A7453913 Q34457158-36B24732-32D0-48A7-A894-8B3B37CE3779 Q34659673-C1D28174-6678-4D7C-88A2-D8BB016EA547 Q34679058-B816672F-BD06-4986-8376-FEBE1A9877A9 Q34738778-09A19081-C386-47B2-98B6-8CA6A199EAA8 Q34954213-8543A011-7CA5-4650-9707-447B778C5839 Q34988159-4194E76B-D789-4F43-831E-54E578A5F422 Q34995998-0AD4C9E0-4F3A-437C-B479-1101232E366D Q35097284-99656E3A-20CC-4B22-935C-2D67F77B2E8B Q35177262-C4370DCB-D27A-40B7-83FE-50A19918BB4F Q35202559-B4A86A29-0063-43B1-A524-0792ECC6922F Q35215604-E617C526-7178-4FED-9CCC-64F5562E2886 Q35524174-72B22D00-9C3E-453A-8254-941FC1D9CF4A Q35798084-5D80D86E-1729-48D5-B372-315C4FD019F7 Q35914957-EFD1B6D9-B4AE-4D3A-BE8B-2E1AA5142B7D Q35932398-EC99C01D-6584-46AE-881F-456352DBCBED Q35946458-772AE1EA-FF0B-462D-8E1D-B5978D401897 Q36023373-4B12661C-BFDE-475E-951D-9B92C10074AD Q36085535-34558188-E464-46A9-BEC0-2D9318F32D2D Q36215217-D57C78B2-3BD5-4024-B5AA-4D5084C17C0E Q36331560-7AE48DA9-839D-4C87-8AD9-6EA3F9603960 Q36427698-23DA8116-76B6-488C-817E-59DA8E8F463E

P2860

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury.

http://www.wikidata.org/entity/Q44060069

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh

2002年學術文章

@zh-hant

name

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury.

@en

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury.

@nl

type

label

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury.

@en

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury.

@nl

prefLabel

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury.

@en

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury.

@nl

P1433

Q44060069-73048BD6-FF11-4108-871C-6981DCA5A4CF

P1476

Q44060069-877A7394-E4E5-444C-A4FA-BCC5F62AAAB9

P2093

Q44060069-126A6266-2D98-4AEA-9CB0-1883DF186747

Q44060069-38BACF0D-D497-4711-8E18-DB992DDB3AAA

Q44060069-75BEFDE1-8873-41F7-ACF6-49553BB9CBFD

Q44060069-9BEDFFA1-E7DE-4A6A-A026-25E17B762904

Q44060069-FB6FA354-D891-4CCD-84D2-E7CE49139FF4

P2860

Q44060069-03B8E923-A2E2-4947-9CC3-A8E98613CBBC

Q44060069-07B62AC7-98D5-4E53-8ADF-7E9C95E7F3C4

Q44060069-0F09FD51-E0F2-493D-8A7C-1476FB6B72F9

Q44060069-191F636F-A4C2-404A-9B57-6CE53B9D58A2

Q44060069-196DE03C-BBA3-4D9A-BF7C-338B0C68AC5F

Q44060069-1C6DD44B-05A7-4242-909F-A2593DBD7F33

Q44060069-1EEF50D3-68B5-4AAC-8539-B4E239DECC1E

Q44060069-25E2ED22-42E6-454E-9198-48D2607E0486

Q44060069-2BD11AD7-CAEA-4FA2-9B9B-FF4AEACA0661

Q44060069-2FCEFFC3-9458-4DF3-87F0-CE4203D1C7CB

P304

Q44060069-69A05F16-4E47-431B-BF93-B6F04C0C3EA8

P31

Q44060069-85F28456-F9F1-4A1D-954C-97BF84F73725

P356

Q44060069-74F9C193-EA75-4C5E-ACC9-4B64A2598053

P433

Q44060069-F6E49AB2-7E56-471C-B45A-1B7AF948566F

P478

Q44060069-07F5FC02-52A9-45D5-8071-2E4C4DA172D0

P50

Q44060069-4BE6A2E7-CA5B-45A3-B2F6-09A9701BD141

P577

Q44060069-B73F8DB1-50D8-42C4-8227-5CF4F9F17273

P5875

Q44060069-F759B829-858F-4A1B-87DA-884A46DCD9B0

P698

Q44060069-B188F977-10E7-4308-8D84-D3CB8759FD5D

P921

Q44060069-BEAEB447-E366-4DC2-8C43-F6A4B75B17E7

P356

P1433

Annals of Neurology

P1476

Minocycline markedly protects the neonatal brain against hypoxic-ischemic injury.

@en

P2093

Byung H Han

http://www.w3.org/2001/XMLSchema#string

Kara L Arvin

http://www.w3.org/2001/XMLSchema#string

Steven M Paul

http://www.w3.org/2001/XMLSchema#string

Sui-zhen Lin

http://www.w3.org/2001/XMLSchema#string

Yansheng Du

http://www.w3.org/2001/XMLSchema#string

P2860

Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs

Posthypoxic cooling of neonatal rats provides protection against brain injury

A novel mechanism of action of tetracyclines: effects on nitric oxide synthases

Interferons and cerebral palsy.

Mice deficient in interleukin-1 converting enzyme are resistant to neonatal hypoxic-ischemic brain damage.

Neonatal cytokines and coagulation factors in children with cerebral palsy.

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

Calpain and caspase: can you tell the difference?

Fetal exposure to an intra-amniotic inflammation and the development of cerebral palsy at the age of three years.

Systematic review of therapy after hypoxic-ischaemic brain injury in the perinatal period.

P304

54-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ANA.10242

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

David M. Holtzman

P577

2002-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11266635

http://www.w3.org/2001/XMLSchema#string

P698

12112047

http://www.w3.org/2001/XMLSchema#string

P921